{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:46:53Z","timestamp":1759160813712},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.antiviral.2016.08.023","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T02:47:52Z","timestamp":1472611672000},"page":"144-152","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Phenotypic and genotypic analysis of influenza viruses isolated from adult subjects during a phase II study of intravenous zanamivir in hospitalised subjects"],"prefix":"10.1016","volume":"134","author":[{"given":"Phillip J.","family":"Yates","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn S.","family":"Raimonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry H.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choy Y.","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen M.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalini","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda F.","family":"Peppercorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.08.023_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/135965350701200S04.1","article-title":"Influenza virus susceptibility and resistance to oseltamivir","volume":"12","author":"Aoki","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2016.08.023_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/viro.1998.9194","article-title":"The interaction of neuraminidase and hemmagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en","volume":"246","author":"Blick","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.08.023_bib3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jcv.2011.01.013","article-title":"Clinical and virological course of infection with haemagglutinin D222G mutant strain of 2009 pandemic influenza A (H1N1) virus","volume":"50","author":"Chan","year":"2011","journal-title":"J.\u00a0Clin. Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2016.08.023_bib4","doi-asserted-by":"crossref","first-page":"e0119115","DOI":"10.1371\/journal.pone.0119115","article-title":"Adamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations","volume":"10","author":"Dong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.08.023_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/infdis\/jiq040","article-title":"Deep sequencing reveals mixed infection with 2009 pandemic influenza a (H1N1) virus strains and the emergence of oseltamivir resistance","volume":"203","author":"Ghedin","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.08.023_bib6","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/314440","article-title":"Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus","volume":"178","author":"Gubareva","year":"1998","journal-title":"J.\u00a0Infect. Dis."},{"issue":"20","key":"10.1016\/j.antiviral.2016.08.023_bib7","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01200-09","article-title":"Zanamivir-resistant influenza viruses with a novel neuraminidase mutation","volume":"83","author":"Hurt","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.023_bib8","doi-asserted-by":"crossref","unstructured":"Hurt AC, Lee RT, Leang SK, Cui L, Deng YM, Phuah SP, Caldwell N, Freeman K, Komadina N, Smith D, Speers D, Kelso A, Lin RT, Maurer-Stroh S, Barr IG. 2011. Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. Euro Surveill.; 16(23). pii: 19884. Erratum in: Euro Surveill.; 16(27) pii: 19909.","DOI":"10.2807\/ese.16.23.19884-en"},{"key":"10.1016\/j.antiviral.2016.08.023_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jac\/dkh528","article-title":"Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations","volume":"55","author":"Jackson","year":"2005","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.antiviral.2016.08.023_bib10","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.09.19498-en","article-title":"Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010","volume":"15","author":"Kilander","year":"2010","journal-title":"Euro Surveill."},{"key":"10.1016\/j.antiviral.2016.08.023_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.antiviral.2016.08.023_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.antiviral.2012.12.016","article-title":"Influenza antiviral resistance in the Asia-Pacific region during 2011","volume":"97","author":"Leang","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.023_bib13","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/infdis\/jiv288","article-title":"E119D neuraminidase mutation conferring Pan-Resistance to neuraminidase inhibitors in an A(H1N1)pdm09 isolate from a stem-cell transplant recipient","volume":"212","author":"L'Huillier","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.08.023_bib14","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.3390\/v7092850","article-title":"Clinical implications of antiviral resistance in influenza","volume":"7","author":"Li","year":"2015","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.antiviral.2016.08.023_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/infdis\/jit467","article-title":"Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study","volume":"209","author":"Marty","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"issue":"7","key":"10.1016\/j.antiviral.2016.08.023_bib16","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1128\/AAC.47.7.2264-2272.2003","article-title":"Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir","volume":"47","author":"McKimm-Breschkin","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.antiviral.2016.08.023_bib17","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.01339-05","article-title":"Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 Years of their use","volume":"50","author":"Monto","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.023_bib18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1086\/656439","article-title":"Recovery of a multi-drug resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y\/I223R mutation from a child after prolonged treatment with oseltamivir","volume":"51","author":"Nguyen","year":"2010","journal-title":"Clin. Inf. Dis."},{"key":"10.1016\/j.antiviral.2016.08.023_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3851\/IMP2067","article-title":"Neuraminidase Inhibitor resistance in influenza viruses and laboratory testing methods","volume":"17","author":"Nguyen","year":"2012","journal-title":"Antivir. Ther."},{"issue":"2","key":"10.1016\/j.antiviral.2016.08.023_bib20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.antiviral.2009.11.005","article-title":"Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses","volume":"85","author":"Okomo-Adhiambo","year":"2009","journal-title":"Antivir. Res."},{"issue":"5","key":"10.1016\/j.antiviral.2016.08.023_bib21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/AAC.01608-09","article-title":"Detection of E119V and E119I mutations in influenza a (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance","volume":"54","author":"Okomo-Adhiambo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.023_bib22","series-title":"OPTIONS for the Control of Influenza Congress, Cape Town, SA","article-title":"Clinical outcomes, viral load and pharmacokinetics following treatment with IV zanamivir in hospitalized adults with influenza: results from a Phase 2 open-label, multicenter, single arm study initiated during the influenza A H1N1 pandemic","author":"Peppercorn","year":"2013"},{"key":"10.1016\/j.antiviral.2016.08.023_bib23","series-title":"OPTIONS for the Control of Influenza Congress, Hong Kong, Abstract, P-198","article-title":"Emergence of successive mutations in the neuraminidase of the pandemic H1N1 virus respectively associated with oseltamivir resistance and reduced susceptibility to both oseltamivir and zanamivir under treatment with neuraminidase inhibitors","author":"Rousset","year":"2010"},{"key":"10.1016\/j.antiviral.2016.08.023_bib24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.antiviral.2009.10.022","article-title":"Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing","volume":"85","author":"Sheu","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.023_bib25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/infdis\/jiv245","article-title":"Emergence of multidrug-resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child treated with oseltamivir and zanamivir","volume":"212","author":"Tamura","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.08.023_bib26","first-page":"421","article-title":"Influenza M2 ion-channel and neuraminidase inhibitors","volume":"vol. 1","author":"Tisdale","year":"2009"},{"key":"10.1016\/j.antiviral.2016.08.023_bib27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3851\/IMP1635","article-title":"Emergence of intratreatment resistance to oseltamivir in pandemic influenza A H1N1 2009 virus","volume":"15","author":"Valinotto","year":"2010","journal-title":"Antivir. Ther."},{"issue":"14","key":"10.1016\/j.antiviral.2016.08.023_bib28","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1003749","article-title":"Emergence of a multi-drug resistant pandemic influenza A (H1N1) virus","volume":"363","author":"van der Vries","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.08.023_bib29","series-title":"Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza","author":"World Health Organisation","year":"2011"},{"key":"10.1016\/j.antiviral.2016.08.023_bib30","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility - Geneva, November 2011 and June 2012","volume":"87","author":"World Health Organisation","year":"2012","journal-title":"Wkly. Epidemiol. Rec."},{"issue":"4","key":"10.1016\/j.antiviral.2016.08.023_bib31","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1128\/AAC.02145-12","article-title":"Virus susceptibility analyses from a phase IV clinical trial of inhaled zanamivir treatment in children infected with influenza","volume":"57","author":"Yates","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.023_bib32","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jac\/dkl321","article-title":"Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in\u00a0vitro","volume":"58","author":"Zurcher","year":"2006","journal-title":"J.\u00a0Antimicrob. Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216304636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216304636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T09:08:51Z","timestamp":1657184931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216304636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":32,"alternative-id":["S0166354216304636"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.023","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic and genotypic analysis of influenza viruses isolated from adult subjects during a phase II study of intravenous zanamivir in hospitalised subjects","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}